200 related articles for article (PubMed ID: 12423254)
1. Galanin inhibits tyrosine hydroxylase expression in midbrain dopaminergic neurons.
Counts SE; McGuire SO; Sortwell CE; Crawley JN; Collier TJ; Mufson EJ
J Neurochem; 2002 Oct; 83(2):442-51. PubMed ID: 12423254
[TBL] [Abstract][Full Text] [Related]
2. Influence of chronic administration of antidepressant drugs on mRNA for galanin, galanin receptors, and tyrosine hydroxylase in catecholaminergic and serotonergic cell-body regions in rat brain.
Rovin ML; Boss-Williams KA; Alisch RS; Ritchie JC; Weinshenker D; West CH; Weiss JM
Neuropeptides; 2012 Apr; 46(2):81-91. PubMed ID: 22317959
[TBL] [Abstract][Full Text] [Related]
3. Activation of galanin receptor 1 inhibits locus coeruleus neurons via GIRK channels.
Bai YF; Ma HT; Liu LN; Li H; Li XX; Yang YT; Xue B; Wang D; Xu ZD
Biochem Biophys Res Commun; 2018 Sep; 503(1):79-85. PubMed ID: 29852172
[TBL] [Abstract][Full Text] [Related]
4. Effect of GDNF on differentiation of cultured ventral mesencephalic dopaminergic and non-dopaminergic calretinin-expressing neurons.
Schaller B; Andres RH; Huber AW; Meyer M; Pérez-Bouza A; Ducray AD; Seiler RW; Widmer HR
Brain Res; 2005 Mar; 1036(1-2):163-72. PubMed ID: 15725414
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the developing dopamine neuron phenotype in cultures of embryonic rat mesencephalon and hypothalamus.
Kapatos G; Hirayama K
Neurochem Int; 1994 Oct; 25(4):309-19. PubMed ID: 7820064
[TBL] [Abstract][Full Text] [Related]
6. Cell-type specific expression and behavioral impact of galanin and GalR1 in the locus coeruleus during opioid withdrawal.
Foster SL; Galaj E; Karne SL; Ferré S; Weinshenker D
Addict Biol; 2021 Sep; 26(5):e13037. PubMed ID: 33768673
[TBL] [Abstract][Full Text] [Related]
7. Regulation of kindling epileptogenesis by hippocampal galanin type 1 and type 2 receptors: The effects of subtype-selective agonists and the role of G-protein-mediated signaling.
Mazarati A; Lundström L; Sollenberg U; Shin D; Langel U; Sankar R
J Pharmacol Exp Ther; 2006 Aug; 318(2):700-8. PubMed ID: 16699066
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic development of prenatal ventral mesencephalon and striatum in organotypic co-cultures.
Lyng GD; Snyder-Keller A; Seegal RF
Brain Res; 2007 Feb; 1133(1):1-9. PubMed ID: 17196555
[TBL] [Abstract][Full Text] [Related]
9. Differential galanin receptor-1 and galanin expression by 5-HT neurons in dorsal raphé nucleus of rat and mouse: evidence for species-dependent modulation of serotonin transmission.
Larm JA; Shen PJ; Gundlach AL
Eur J Neurosci; 2003 Feb; 17(3):481-93. PubMed ID: 12581166
[TBL] [Abstract][Full Text] [Related]
10. Galanin inhibits neural activity in the subfornical organ in rat slice preparation.
Kai A; Ono K; Kawano H; Honda E; Nakanishi O; Inenaga K
Neuroscience; 2006 Dec; 143(3):769-77. PubMed ID: 17027169
[TBL] [Abstract][Full Text] [Related]
11. Characterization of GalR1, GalR2, and GalR3 immunoreactivity in catecholaminergic nuclei of the mouse brain.
Hawes JJ; Picciotto MR
J Comp Neurol; 2004 Nov; 479(4):410-23. PubMed ID: 15514977
[TBL] [Abstract][Full Text] [Related]
12. Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP.
Mena MA; Casarejos MJ; Bonin A; Ramos JA; García Yébenes J
J Neurochem; 1995 Dec; 65(6):2612-20. PubMed ID: 7595558
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine hydroxylase mRNA expression by dopaminergic neurons in culture: effect of 1-methyl-4-phenylpyridinium treatment.
Beck KD; Knusel B; Pasinetti G; Michel PP; Zawadzka H; Goldstein M; Hefti F
J Neurochem; 1991 Aug; 57(2):527-32. PubMed ID: 1677030
[TBL] [Abstract][Full Text] [Related]
14. Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia.
Peng GS; Li G; Tzeng NS; Chen PS; Chuang DM; Hsu YD; Yang S; Hong JS
Brain Res Mol Brain Res; 2005 Mar; 134(1):162-9. PubMed ID: 15790540
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of erythropoietin on 6-hydroxydopamine-treated ventral mesencephalic dopamine-rich cultures.
Ganser C; Papazoglou A; Just L; Nikkhah G
Exp Cell Res; 2010 Mar; 316(5):737-46. PubMed ID: 20060824
[TBL] [Abstract][Full Text] [Related]
16. Tyrosine hydroxylase mRNA concentration in midbrain dopaminergic neurons is differentially regulated by reserpine.
Pasinetti GM; Morgan DG; Johnson SA; Millar SL; Finch CE
J Neurochem; 1990 Nov; 55(5):1793-9. PubMed ID: 1976760
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo.
Farkas LM; Dünker N; Roussa E; Unsicker K; Krieglstein K
J Neurosci; 2003 Jun; 23(12):5178-86. PubMed ID: 12832542
[TBL] [Abstract][Full Text] [Related]
18. CGP 3466 increases survival of cultured fetal dopaminergic neurons.
Matarredona ER; Meyer M; Seiler RW; Widmer HR
Restor Neurol Neurosci; 2003; 21(1-2):29-37. PubMed ID: 12808200
[TBL] [Abstract][Full Text] [Related]
19. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
20. The response of human and rat fetal ventral mesencephalon in culture to the brain-derived neurotrophic factor treatment.
Zhou J; Bradford HF; Stern GM
Brain Res; 1994 Sep; 656(1):147-56. PubMed ID: 7804829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
